Back to Search Start Over

Phase 3b Trial of Fezolinetant Shows Positive Topline Results for Treatment of VMS Due to Menopause

Source :
Women's Health Weekly. July 13, 2023, 52
Publication Year :
2023

Abstract

2023 JUL 13 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, 'Astellas') announced positive topline [...]

Details

Language :
English
ISSN :
10787240
Database :
Gale General OneFile
Journal :
Women's Health Weekly
Publication Type :
Periodical
Accession number :
edsgcl.756566457